-
Single-cell profiling maps the spectrum of crosstalk between glioma cells and tumor associated macrophages
Study
EGAS00001002185
-
463 newly diagnosed patients with Multiple Myeloma underwent whole exome sequencing of tumour and peripheral blood DNA.
Study
EGAS00001001147
-
Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study
Study
EGAS00001001516
-
Anaplastic_Meningioma_V3__cancer_gene_panel
Study
EGAS00001001155
-
Copy number profiling of primary samples and cell lines of retinoblastoma
Study
EGAS00001001715
-
Osteosarcoma_RNAseq
Study
EGAS00001000615
-
ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells-of-origin
Study
EGAS00001004913
-
Integration of genomics and histology reveals diagnosis and effective therapy of refractory cancer of unknown primary with PDL1 amplification (H021)
Study
EGAS00001001846
-
EATL-II STUDY
Study
EGAS00001001879
-
RNA sequencing of CD8 T cells from melanoma patients prior to and during checkpoint immunotherapy and untreated healthy controls
Study
EGAS00001004081
-
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
Study
EGAS00001001916
-
glioblastoma and glioblastoma stem cells (GSCs), RNA-seq and WGS
Study
EGAS00001004395
-
Whole genome shotgun sequencing and somatic mutations data in Hepatocellular carcinoma
Study
EGAS00001002578
-
Spatial genomic heterogeneity in multiple myeloma revealed by multi- region sequencing
Study
EGAS00001002111
-
RNA-sequencing of six Pilocytic astrocytoma tumors
Study
EGAS00001002149
-
Genetic analysis of HLA and immune escape genes in Diffuse Large B-cell Lymphoma
Study
EGAS00001005054
-
miR-200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Study
EGAS00001002184
-
An Unusual Genomic Variant of Pancreatic Ductal Adenocarcinoma with an Indolent Clinical Course
Study
EGAS00001002192
-
Transcriptional mechanisms of resistance to anti-PD-1 therapy
Study
EGAS00001002195
-
The genomic landscape of Burkitt Lymphoma
Study
EGAS00001002198
-
Orthotopic Patient-Derived Xenografts of Pediatric Solid Tumors
Study
EGAS00001002528
-
Gtag&T single-cell genome and transcriptome data
Study
EGAS00001007043
-
Genomic characterization of retinoblastoma (targeted sequencing)
Study
EGAS00001005550
-
Whole genome sequencing of acral melanomas
Study
EGAS00001000486
-
Poly(A) RNA sequencing of hepatocellular carcinoma tumors and their matched noncancerous liver tissues
Study
EGAS00001002337
-
Targeted sequencing of follicular lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001005238
-
Evolutionary predictability of genetic versus non genetic resistance to anticancer drugs in melanoma
Study
EGAS00001005314
-
Genomics of enteropathy associated T cell lymphoma (EATL)
Study
EGAS00001001954
-
Neuroblastoma tumor heterogeneity and cell plasticity (from patients)
Study
EGAS00001005322
-
Integrative genomic and transcriptomic analysis of adult leiomyosarcoma (HIPO-028, HIPO-018, HIPO-021)
Study
EGAS00001002437
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing - NGS targeted capture control cohort
Study
EGAS00001005325
-
Successful immune checkpoint blockade in a patient with advanced stage microsatellite unstable biliary tract cancer (H021)
Study
EGAS00001002441
-
Mutational spectrum of highly differentiated, fusion-negative rhabdomyosarcoma (set 1).
Study
EGAS00001002630
-
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Study
EGAS00001000399
-
Spatial concordance of DNA methylation classification in diffuse glioma
Study
EGAS00001005434
-
Integrated genomic analyses reveal molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Study
EGAS00001005503
-
Genomic and transcriptomic profiling of signalling networks in follicular lymphoma
Study
EGAS00001002175
-
PanCuRx Translational Research Initiative
Study
EGAS00001002543
-
Pre-neoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma
Study
EGAS00001005656
-
Exome sequencing data from two myelosarcomas
Study
EGAS00001002562
-
Systematic kinase inhibitor profiling identifies CDK9 as a synthetic lethal target in NUT midline carcinoma
Study
EGAS00001002588
-
Mesothelioma_Whole_Genomes
Study
EGAS00001000830
-
The exomic landscape of t(14,18) negative diffuse follicular lymphoma with 1p36 deletion
Study
EGAS00001002594
-
Brain_Disease_Wellcome_Leap_Delta_Tissue_DNA
Study
EGAS00001005799
-
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Study
EGAS00001000579
-
Identification of a Fumarate-Hydratase Deficient-like RCC Subtype with Convergent Pathway Alterations
Study
EGAS00001002646
-
Gut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
Study
EGAS00001002698
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study
EGAS00001005981
-
Leiden_melanomafamilies
Study
EGAS00001000627
-
CD74-NRG1 fusions in lung adenocarcinoma
Study
EGAS00001000653